<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005">
<channel xmlns:cfi="http://www.microsoft.com/schemas/rss/core/2005/internal" cfi:lastdownloaderror="None">
<title cf:type="text"><![CDATA[Editorial Board of Journal of Pharmaceutical Research -->新冠肺炎专题]]></title>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Uncovery of the action mechanisms and major bioactive compounds responsible for the protective effects of Toujie Quwen Granules on COVID-19 based on network pharmacology and molecular docking]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202012006&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>Objective</b>  To explore the mechanism of action and active constituents of Toujie Quwen Granules (TJQWG) for treatment of COVID-19, and provide a scientific reference for its clinical application.<b>Methods</b>  The constituents of TJQWG were collected by using Traditional Chinese Medicine Systems Pharmacology Database (TCMSP). The targets of constituents were collected by using TCMSP and Toxicogenomics Database (CTD). Protein-protein interaction (PPI) data was constructed by using String website for screening key targets.The herb-active constituent-key target network was constructed by using Cytoscape software, followed by topology analysis. The DAVID database was used to perform KEGG pathway analysis on the key targets and molecular docking study was performed to evaluate the interaction between the active constituents and the targets (ACE2, MPro, and PLP), predicting the mechanism of action of TJQWG.<b>Results</b>  A total of 132 key targets were screened, such as PTGS2, CASP3, IL6, TNF, TP53, AKT1, MAPK3, VEGFA, MAPK1, STAT3, JUN, GAPDH, INS, ALB, AR and so on. Molecular docking results indicated that a total of 58, 64, and 56 active constituents in TJQWG possess lesser binding energies (below the average) to ACE2, MPro, and PLP, respectively. The results of pathway enrichment indicated that Influenza A, Small cell lung cancer, TNF signaling pathway, Toll-like receptor signaling pathway, PI3K/Akt signaling pathway, and HIF-1 signaling pathway were the key pathways, which were involved in the treatment of COVID-19. <b>Conclusion</b>  TJQWG may exhibit therapeutic effects on COVID-19 probably through inhibiting the infection and reproduction of SARS-CoV-2 due to targeting ACE2,MPro and PLP,as well as moderating cytokine release syndrome, hypoxemia, and lung fibrosis based on multi-target and multi-pathway.]]></description>
<pubDate>2021/1/12 9:35:53</pubDate>
<category><![CDATA[新冠肺炎专题]]></category>
<author><![CDATA[RAO Hongyu, CHEN Pan, WU Hao, WANG Yonggang, LI Peibo, SU Weiwei]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>RAO Hongyu, CHEN Pan, WU Hao, WANG Yonggang, LI Peibo, SU Weiwei</atom:name>
</atom:author>
<guid><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202012006&flag=1]]></guid><cfi:id>9</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[A resistance war of "new crown disease" caused me to think about the teaching model of microbiology and immunology]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202012007&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[Microbiology and immunology is an up-to-date and developing basic course for undergraduate students majoring in pharmacy and traditional Chinese medicine. The 2019-NCOV sweeping the world in 2020 opens a new chapter in the teaching of microbiology and immunology. At the same time, the epidemic also triggered my thinking on the teaching of this course: the relevance of epidemic and course knowledge, the optimization and adjustment of teaching content according to the epidemic situation, the creation of online and offline blended course, curriculum ideology and politics. Good teaching effect has been achieved in the teaching practice of this semester. What’s more, the development and improvement of students' professional knowledge has also been promoted in this semester.]]></description>
<pubDate>2021/1/12 9:35:53</pubDate>
<category><![CDATA[新冠肺炎专题]]></category>
<author><![CDATA[SUN Qing, LIU Yanjuan, ZHONG Wenwen]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>SUN Qing, LIU Yanjuan, ZHONG Wenwen</atom:name>
</atom:author>
<guid><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202012007&flag=1]]></guid><cfi:id>8</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Application of traditional Chinese medicine for prevention and treatment of new coronavirus pneumonia]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202011007&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[At present, there are cases of the coronavirus disease 2019（COVID-19）in the world, and the situation of prevention and control of the epidemic is grim. It has the characteristics of strong infectivity, rapid and wide spread and so on.The traditional Chinese medicine has played an important role in the prevention and treatment of COVID-19. The drug dosage forms also play an important role in the efficacy, so when choosing drugs, we should also pay attention to the choice of drug dosage forms. From the point of view of drug dosage form,this article summarizes the network pharmacology research and the pharmacological effect and clinical application of traditional Chinese medicine currently used in the treatment of COVID-19, in order to better play the role of traditional Chinese medicine in fighting the COVID-19,to provide reference for the prevention and treatment of similar viruses in the future, and to promote the rational application of traditional Chinese medicine.]]></description>
<pubDate>2020/12/7 15:11:54</pubDate>
<category><![CDATA[新冠肺炎专题]]></category>
<author><![CDATA[杜月，刘继勇]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>杜月，刘继勇</atom:name>
</atom:author>
<guid><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202011007&flag=1]]></guid><cfi:id>7</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[The Role and Reflections of Institutes for Food and Drug Control in the Background of Novel Coronavirus Pneumonia]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202011008&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[In the battle of prevention and control of novel coronavirus pneumonia,domestic institutes for food and drug control took rapid actions, giving full play to their own professional and detection advantages,taking a number of measures,such as special handling of special cases, combination of sampling and sample testing,group assistance etc.,to provide emergency inspection services for enterprises,and provide strong technical supports for food and drug regulatory authorities, showing the responsibility of institutes for food and drug control.This paper introduces some countermeasures to prevent and control in epidemic situation by institutes for food and drug control.The practical significance and social value of food and drug control are discussed.Some useful thoughts on the working mode changed due to the epidemic are provided.]]></description>
<pubDate>2020/12/7 15:11:54</pubDate>
<category><![CDATA[新冠肺炎专题]]></category>
<author><![CDATA[李樱红，应崇杰，颜琳琦，倪维芳，龚青]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>李樱红，应崇杰，颜琳琦，倪维芳，龚青</atom:name>
</atom:author>
<guid><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202011008&flag=1]]></guid><cfi:id>6</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Research on online teaching model of traditional Chinese medicine specialty under the background of prevention and control of Corona virus disease 2019]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202011009&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[Through investigation and research, this paper analyzes the current situation of online teaching mode of traditional Chinese medicine specialty during the period of prevention and control of Corona virus disease 2019, compares the advantages and disadvantages of different teaching modes, and analyzes the factors that affect students'learning effect, be Aimed at the problems existing in the online teaching process, this paper puts forward some corresponding solutions.We should carry forward the spirit of overcoming the epidemic disease, inspire students'patriotic enthusiasm and firm determination to Pass on and develop the traditional Chinese medicine, provide basis for the reform of online teaching mode in the future, and promote the integration of information technology and education and teaching.]]></description>
<pubDate>2020/12/7 15:11:54</pubDate>
<category><![CDATA[新冠肺炎专题]]></category>
<author><![CDATA[王盈，魏巍，傅红，孙立艳，郑瑾，李璐，黄振宇，窦国义]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>王盈，魏巍，傅红，孙立艳，郑瑾，李璐，黄振宇，窦国义</atom:name>
</atom:author>
<guid><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202011009&flag=1]]></guid><cfi:id>5</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[基于网络药理学及分子对接虚拟筛选疏风解毒胶囊治疗新冠病毒肺炎（COVID-19）活性成分研究]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202109008&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[]]></description>
<pubDate>2021/10/22 16:02:40</pubDate>
<category><![CDATA[新冠肺炎专题]]></category>
<author><![CDATA[谢平<sup>1,2,3</sup>，王晨情<sup>1,2,3</sup>，叶雅惠<sup>1,2,3</sup>，沈金海<sup>1,2,3</sup>，郝春莉<sup>1,2,3</sup>]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>谢平<sup>1,2,3</sup>，王晨情<sup>1,2,3</sup>，叶雅惠<sup>1,2,3</sup>，沈金海<sup>1,2,3</sup>，郝春莉<sup>1,2,3</sup></atom:name>
</atom:author>
<guid><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202109008&flag=1]]></guid><cfi:id>4</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Research progress on COVID-19-related cardiovascular disease]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202104008&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[COVID-19 has rapidly developed into a global health emergency.The COVID-19 virus, or SARS-CoV-2,can affect many organs, especially the lungs and heart.Studies have found that the elevation of cardiac biomarkers,especially high-sensitivity troponin I (hs-cTnI) and creatine kinase (CK),is very common in patients with COVID-19,which is helpful for disease diagnosis and risk stratification.At the same time,it was found that patients with previous cardiovascular diseases were more likely to be infected with SARS-CoV-2.Hypertension,arrhythmia,cardiomyopathy and coronary heart disease were common cardiovascular diseases in severe cases of COVID-19.Nowadays, more and more literatures have discussed the influence of SARS-CoV-2 on the heart,in which myocardial injury is one of the important characteristics of COVID-19.However,the exact mechanism of myocardial injury caused by SARS-CoV-2 remains unclear.At present,the mechanisms of myocardial injury include direct damage to cardiomyocytes by virus,systemic inflammatory response,myocardial fibrosis,interferon-mediated immune response,exaggerated cytokine response of type 1 and type 2 helper T cells,coronary plaque instability and hypoxia.Considering the complex effects of SARS-CoV-2 on the cardiovascular system, we need to further explore the pathogenesis in order to find better treatments that could reduce the incidence and mortality of COVID-19 related acute myocardial injury.]]></description>
<pubDate>2021/5/25 19:40:51</pubDate>
<category><![CDATA[新冠肺炎专题]]></category>
<author><![CDATA[SONG Shuang<sup>1</sup>, SUN Dakang<sup>2</sup>, LI Yang<sup>1</sup>, CHENG Yanli<sup>1</sup>]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>SONG Shuang<sup>1</sup>, SUN Dakang<sup>2</sup>, LI Yang<sup>1</sup>, CHENG Yanli<sup>1</sup></atom:name>
</atom:author>
<guid><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202104008&flag=1]]></guid><cfi:id>3</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Research Progress of TCM in the Treatment of COVID-19]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202209006&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[Traditional Chinese medicine (TCM) is a general term for medicine of all ethnic groups in China, including the medicine of the Han and ethnic minorities. COVID-19, which broke out in late 2019, is one of the most serious infectious diseases in modern times. Since the outbreak of the epidemic, TCM has played an important role in treating COVID-19 infections. This review analyzes the understanding of the novel coronavirus pneumonia in TCM theory, and summarizes the common clinical symptoms of patients with novel coronavirus pneumonia, and introduces the efficacy and possible mechanisms of several TCM in the treatment of novel coronavirus pneumonia, as well as the current clinical use, to provide clinical medication guidance for Chinese medicine to cure new coronavirus pneumonia.]]></description>
<pubDate>2022/10/10 9:39:45</pubDate>
<category><![CDATA[新冠肺炎专题]]></category>
<author><![CDATA[WU Shuling<sup>1,2</sup>, ZHU Yu<sup>3</sup>, ZHENG Dandan<sup>3</sup>, YANG Lehe<sup>3</sup>, ZHAO Chengguang<sup>3</sup>, ZHAO Haiyang<sup>1,2</sup>]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>WU Shuling<sup>1,2</sup>, ZHU Yu<sup>3</sup>, ZHENG Dandan<sup>3</sup>, YANG Lehe<sup>3</sup>, ZHAO Chengguang<sup>3</sup>, ZHAO Haiyang<sup>1,2</sup></atom:name>
</atom:author>
<guid><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202209006&flag=1]]></guid><cfi:id>2</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Protection of subjects in phase I clinical trials during normalized anti-epidemic period]]></title>
<link><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202202008&flag=1]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[The occurrence of COVID-19 has great impact on various industries in China. It also brings a lot of difficulties to the smooth development of clinical trials. At present, long-term anti epidemic is inevitable, and clinical trials during the epidemic have become the norm. In clinical trials, the safety of subjects should be put in the first place.This paper introduces the five clinical trials carried out in the Hospital of Dermatology，Chinese Academy of Medical Sciences and Peking Union Medical College from May 2020 to December 2020,Through a series of measures taken in the early stage, screening period, test period, cleaning period and follow-up period, the safety of subjects is guaranteed, and the reliability and integrity of test data and results are ensured.]]></description>
<pubDate>2022/3/16 16:00:22</pubDate>
<category><![CDATA[新冠肺炎专题]]></category>
<author><![CDATA[CAI Baole, MA Pengcheng]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>CAI Baole, MA Pengcheng</atom:name>
</atom:author>
<guid><![CDATA[http://www.yaoxueyanjiu.org.cn/ch/reader/view_abstract.aspx?file_no=202202008&flag=1]]></guid><cfi:id>1</cfi:id><cfi:read>true</cfi:read></item>
</channel>
</rss>